NEW YORK (GenomeWeb News) – Expression Pathology plans to use a $148,000 grant from the National Cancer Institute to identify biomarkers and develop breast cancer diagnostic technology, the company said today.
 
Gaithersburg, Md.-based EPI said it will use the Small Business Innovation Research grant to use its microproteomics technologies to identify protein biomarkers of metastasis in primary breast cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.